Having trouble accessing articles? Reset your cache.

Aricept donepezil regulatory update

The U.K.'s NICE issued an appraisal consultation document that would allow for the broadened use of 4 Alzheimer's disease (AD) drugs that were restricted

Read the full 246 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE